NEW YORK — UK immunodiagnostics firm Oncimmune said today that a distribution partner for its EarlyCDT Lung cancer assay has signed a sales and marketing agreement for the test with Spanish private healthcare organization Vithas Group.
NEW YORK — UK immunodiagnostics firm Oncimmune said today that a distribution partner for its EarlyCDT Lung cancer assay has signed a sales and marketing agreement for the test with Spanish private healthcare organization Vithas Group.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.